Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proton therapy for the treatment of inflammatory breast cancer.
Fattahi S, Mullikin TC, Aziz KA, Afzal A, Smith NL, Francis LN, Harmsen WS, Routman DM, Remmes NB, Ahmed SK, Shumway DA, Park SS, Mutter RW, Corbin KS. Fattahi S, et al. Among authors: afzal a. Radiother Oncol. 2022 Jun;171:77-83. doi: 10.1016/j.radonc.2022.04.008. Epub 2022 Apr 15. Radiother Oncol. 2022. PMID: 35436537 Free article.
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes.
Gao RW, Mullikin TC, Aziz KA, Afzal A, Smith NL, Routman DM, Gergelis KR, Harmsen WS, Remmes NB, Tseung HSWC, Shiraishi SS, Boughey JC, Ruddy KJ, Harless CA, Garda AE, Waddle MR, Park SS, Shumway DA, Corbin KS, Mutter RW. Gao RW, et al. Among authors: afzal a. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):846-856. doi: 10.1016/j.ijrobp.2023.05.036. Epub 2023 May 26. Int J Radiat Oncol Biol Phys. 2023. PMID: 37244627 Free article.
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
Mutter RW, Giri S, Fruth BF, Remmes NB, Boughey JC, Harless CA, Ruddy KJ, McGee LA, Afzal A, Gao RW, Shumway DA, Vern-Gross TZ, Villarraga HR, Kenison SL, Kang Y, Wong WW, Stish BJ, Merrell KW, Yan ES, Park SS, Corbin KS, Vargas CE. Mutter RW, et al. Among authors: afzal a. Lancet Oncol. 2023 Oct;24(10):1083-1093. doi: 10.1016/S1470-2045(23)00388-1. Epub 2023 Sep 8. Lancet Oncol. 2023. PMID: 37696281 Free PMC article. Clinical Trial.
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
Mutter RW, Golafshar MA, Buras MR, Comstock BP, Jacobson M, DeWees T, Remmes NB, Francis LN, Boughey JC, Ruddy KJ, McGee LA, Afzal A, Vallow LA, Furutani KM, Deufel CL, Shumway DA, Kim H, Liu MC, Degnim AC, Jakub JW, Vern-Gross TZ, Wong WW, Patel SH, Vargas CE, Stish BJ, Waddle MR, Pafundi DH, Halyard MY, Corbin KS, Hieken TJ, Park SS. Mutter RW, et al. Among authors: afzal a. Int J Radiat Oncol Biol Phys. 2024 Sep 17:S0360-3016(24)03389-3. doi: 10.1016/j.ijrobp.2024.09.019. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39299551 Free article.
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity.
Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Herrmann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. Gupta S, et al. Among authors: afzal a. Blood. 2025 Jan 6:blood.2024026211. doi: 10.1182/blood.2024026211. Online ahead of print. Blood. 2025. PMID: 39760780
693 results